Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer’s disease (original) (raw)

• Querfurth HW, LaFerla FM . Alzheimer's disease. N Engl J Med 2010; 362: 329–344.
  Article CAS Google Scholar
• Muller WE, Eckert A, Kurz C, Eckert GP, Leuner K . Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease—therapeutic aspects. Mol Neurobiol 2010; 41: 159–171.
  Article Google Scholar
• Reddy PH, Beal MF . Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 2008; 14: 45–53.
  Article CAS Google Scholar
• Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH . Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006; 15: 1437–1449.
  Article CAS Google Scholar
• Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 2008; 105: 13145–13150.
  Article CAS Google Scholar
• Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK . Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 2006; 26: 9057–9068.
  Article CAS Google Scholar
• Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG . Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161: 41–54.
  Article CAS Google Scholar
• Muirhead KE, Borger E, Aitken L, Conway SJ, Gunn-Moore FJ . The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease. Biochem J 2010; 426: 255–270.
  Article CAS Google Scholar
• Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008; 105: 19318–19323.
  Article CAS Google Scholar
• Pavlov PF, Wiehager B, Sakai J, Frykman S, Behbahani H, Winblad B et al. Mitochondrial gamma-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. FASEB J 2011; 25: 78–88.
  Article CAS Google Scholar
• Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH . Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 2011; 20: 4515–4529.
  Article CAS Google Scholar
• Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017–3023.
  Article CAS Google Scholar
• Xie H, Guan J, Borrelli LA, Xu J, Serrano-Pozo A, Bacskai BJ . Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model. J Neurosci 2013; 33: 17042–17051.
  Article CAS Google Scholar
• Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M et al. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 2007; 3: 614–615.
  Article CAS Google Scholar
• Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD . Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009; 106: 14670–14675.
  Article CAS Google Scholar
• Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A et al. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol Psychiatry 2008; 13: 953–969.
  Article CAS Google Scholar
• Rhein V, Baysang G, Rao S, Meier F, Bonert A, Muller-Spahn F et al. Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 2009; 29: 1063–1071.
  Article CAS Google Scholar
• Mattson MP, Partin J, Begley JG . Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res 1998; 807: 167–176.
  Article CAS Google Scholar
• Matsumoto K, Akao Y, Yi H, Shamoto-Nagai M, Maruyama W, Naoi M . Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells. J Neural Transm (Vienna) 2006; 113: 125–135.
  Article CAS Google Scholar
• Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004; 304: 448–452.
  Article CAS Google Scholar
• Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997; 69: 273–284.
  Article CAS Google Scholar
• Crouch PJ, Harding SM, White AR, Camakaris J, Bush AI, Masters CL . Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease. Int J Biochem Cell Biol 2008; 40: 181–198.
  Article CAS Google Scholar
• Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA . Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 2002; 80: 91–100.
  Article CAS Google Scholar
• Aleardi AM, Benard G, Augereau O, Malgat M, Talbot JC, Mazat JP et al. Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr 2005; 37: 207–225.
  Article CAS Google Scholar
• Abramov AY, Canevari L, Duchen MR . Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 2004; 24: 565–575.
  Article CAS Google Scholar
• Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309–313.
  Article CAS Google Scholar
• Smith WW, Norton DD, Gorospe M, Jiang H, Nemoto S, Holbrook NJ et al. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J Cell Biol 2005; 169: 331–339.
  Article CAS Google Scholar
• Bashir M, Parray AA, Baba RA, Bhat HF, Bhat SS, Mushtaq U et al. beta-Amyloid-evoked apoptotic cell death is mediated through MKK6-p66shc pathway. Neuromol Med 2014; 16: 137–149.
  Article CAS Google Scholar
• Berry A, Capone F, Giorgio M, Pelicci PG, de Kloet ER, Alleva E et al. Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp Gerontol 2007; 42: 37–45.
  Article CAS Google Scholar
• Berry A, Greco A, Giorgio M, Pelicci PG, de Kloet R, Alleva E et al. Deletion of the lifespan determinant p66(Shc) improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice. Exp Gerontol 2008; 43: 200–208.
  Article CAS Google Scholar
• Camici GG, Schiavoni M, Francia P, Bachschmid M, Martin-Padura I, Hersberger M et al. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 2007; 104: 5217–5222.
  Article CAS Google Scholar
• Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 2004; 110: 2889–2895.
  Article CAS Google Scholar
• Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P et al. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 2003; 100: 2112–2116.
  Article CAS Google Scholar
• Berniakovich I, Trinei M, Stendardo M, Migliaccio E, Minucci S, Bernardi P et al. p66Shc-generated oxidative signal promotes fat accumulation. J Biol Chem 2008; 283: 34283–34293.
  Article CAS Google Scholar
• Francia P, Cosentino F, Schiavoni M, Huang Y, Perna E, Camici GG et al. p66(Shc) protein, oxidative stress, and cardiovascular complications of diabetes: the missing link. J Mol Med (Berl) 2009; 87: 885–891.
  Article CAS Google Scholar
• Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F et al. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 2006; 55: 1642–1650.
  Article CAS Google Scholar
• Menini S, Iacobini C, Ricci C, Oddi G, Pesce C, Pugliese F et al. Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Diabetologia 2007; 50: 1997–2007.
  Article CAS Google Scholar
• Pagnin E, Fadini G, de Toni R, Tiengo A, Calo L, Avogaro A . Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab 2005; 90: 1130–1136.
  Article CAS Google Scholar
• Ranieri SC, Fusco S, Panieri E, Labate V, Mele M, Tesori V et al. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proc Natl Acad Sci USA 2010; 107: 13420–13425.
  Article CAS Google Scholar
• Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004; 13: 159–170.
  Article CAS Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG . Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
  Article Google Scholar
• Kulic L, McAfoose J, Welt T, Tackenberg C, Spani C, Wirth F et al. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Abeta APP mutation. Transl Psychiatry 2012; 2: e183.
  Article CAS Google Scholar
• Franklin BJ, Paxinos GT . The Mouse Brain in Stereotaxic Coordinates. Academic Press: New York, 1996.
  Google Scholar
• Spani C, Suter T, Derungs R, Ferretti MT, Welt T, Wirth F et al. Reduced beta-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells. Acta Neuropathol Commun 2015; 3: 71.
  Article Google Scholar
• Hurst JL, West RS . Taming anxiety in laboratory mice. Nat Methods 2010; 7: 825–826.
  Article CAS Google Scholar
• Kulic L, Wollmer MA, Rhein V, Pagani L, Kuehnle K, Cattepoel S et al. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiol Aging 2011; 32: 1827–1838.
  Article CAS Google Scholar
• David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem 2005; 280: 23802–23814.
  Article CAS Google Scholar
• Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA 2009; 106: 20057–20062.
  Article CAS Google Scholar
• Halford RW, Russell DW . Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan. Proc Natl Acad Sci USA 2009; 106: 3502–3506.
  Article CAS Google Scholar
• Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30: 6367–6374.
  Article CAS Google Scholar
• Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP et al. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 2005; 18: 602–617.
  Article CAS Google Scholar
• Volianskis A, Kostner R, Molgaard M, Hass S, Jensen MS . Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1deltaE9-deleted transgenic mice model of ss-amyloidosis. Neurobiol Aging 2010; 31: 1173–1187.
  Article CAS Google Scholar
• Underwood E . NEUROSCIENCE. Alzheimer's amyloid theory gets modest boost. Science 2015; 349: 464.
  Article CAS Google Scholar
• Reardon S . Antibody drugs for Alzheimer's show glimmers of promise. Nature 2015; 523: 509–510.
  Article CAS Google Scholar
• Toyn J . What lessons can be learned from failed Alzheimer's disease trials? Expert Rev Clin Pharmacol 2015; 8: 267–269.
  Article CAS Google Scholar
• Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D et al. Building a roadmap for developing combination therapies for Alzheimer's disease. Expert Rev Neurother 2015; 15: 327–333.
  Article CAS Google Scholar
• Lalonde R, Kim HD, Maxwell JA, Fukuchi K . Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett 2005; 390: 87–92.
  Article CAS Google Scholar
• Jackson HM, Onos KD, Pepper KW, Graham LC, Akeson EC, Byers C et al. DBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease. PLoS ONE 2015; 10: e0125897.
  Article Google Scholar
• Chan J, Jones NC, Bush AI, O'Brien TJ, Kwan P . A mouse model of Alzheimer's disease displays increased susceptibility to kindling and seizure-associated death. Epilepsia 2015; 56: e73–e77.
  Article Google Scholar
• Westmark CJ, Westmark PR, Beard AM, Hildebrandt SM, Malter JS . Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. Int J Clin Exp Pathol 2008; 1: 157–168.
  CAS PubMed PubMed Central Google Scholar
• Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007; 55: 697–711.
  Article CAS Google Scholar
• Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L et al. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 2009; 29: 3453–3462.
  Article CAS Google Scholar
• Moreira PI, Sayre LM, Zhu X, Nunomura A, Smith MA, Perry G . Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease. Methods Mol Biol 2010; 610: 419–434.
  Article CAS Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J . Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44–84.
  Article CAS Google Scholar
• Subbarao KV, Richardson JS, Ang LC . Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 1990; 55: 342–345.
  Article CAS Google Scholar
• Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA . 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997; 68: 2092–2097.
  Article CAS Google Scholar
• Butterfield DA, Lauderback CM . Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 2002; 32: 1050–1060.
  Article CAS Google Scholar
• Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM . Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001; 21: 4183–4187.
  Article CAS Google Scholar
• Hong Y, An Z . Hesperidin attenuates learning and memory deficits in APP/PS1 mice through activation of Akt/Nrf2 signaling and inhibition of RAGE/NF-kappaB signaling. Arch Pharm Res 2015.
• Zhou Y, Xie N, Li L, Zou Y, Zhang X, Dong M . Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. Int J Neuropsychopharmacol 2014; 17: 635–644.
  Article Google Scholar
• Jin JL, Liou AK, Shi Y, Yin KL, Chen L, Li LL et al. CART treatment improves memory and synaptic structure in APP/PS1 mice. Sci Rep 2015; 5: 10224.
  Article CAS Google Scholar
• Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002; 21: 3872–3878.
  Article CAS Google Scholar
• Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G . Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta 2010; 1802: 2–10.
  Article CAS Google Scholar
• Bo H, Kang W, Jiang N, Wang X, Zhang Y, Ji LL . Exercise-induced neuroprotection of hippocampus in APP/PS1 transgenic mice via upregulation of mitochondrial 8-oxoguanine DNA glycosylase. Oxid Med Cell Longev 2014; 2014: 834502.
  Article Google Scholar
• Schuh RA, Jackson KC, Schlappal AE, Spangenburg EE, Ward CW, Park JH et al. Mitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer's disease-relevant murine model. BMC Neurosci 2014; 15: 24.
  Article Google Scholar
• Long AN, Owens K, Schlappal AE, Kristian T, Fishman PS, Schuh RA . Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model. BMC Neurol 2015; 15: 19.
  Article Google Scholar
• Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW et al. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis 2010; 20: S535–S550.
  Article Google Scholar
• Lu L, Guo L, Gauba E, Tian J, Wang L, Tandon N et al. Transient cerebral ischemia promotes brain mitochondrial dysfunction and exacerbates cognitive impairments in young 5xFAD mice. PLoS ONE 2015; 10: e0144068.
  Article Google Scholar
• Hirst J, King MS, Pryde KR . The production of reactive oxygen species by complex I. Biochem Soc Trans 2008; 36: 976–980.
  Article CAS Google Scholar
• Orth M, Schapira AH . Mitochondria and degenerative disorders. Am J Med Genet 2001; 106: 27–36.
  Article CAS Google Scholar
• Hroudova J, Singh N, Fisar Z . Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease. Biomed Res Int 2014; 2014: 175062.
  Article Google Scholar
• Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005; 122: 221–233.
  Article CAS Google Scholar